---
title: "Amwill Health Care Ltd (544353) — Share Price, Financials & Analysis"
symbol: "544353"
company: "Amwill Health Care Ltd"
canonical: "https://tapetide.com/stocks/544353"
isin: "INE0U2L01017"
nse_symbol: "AMWILLHEALTHCARELTD"
bse_code: "544353"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 86
generated_at: "2026-09-13T19:16:06.726Z"
---

# Amwill Health Care Ltd (544353)

Canonical page: https://tapetide.com/stocks/544353

## Company

- **NSE Symbol:** AMWILLHEALTHCARELTD
- **BSE Code:** 544353
- **ISIN:** INE0U2L01017
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-02-12
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** amwillhealthcare.com

## About

Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:46:17.973416Z.

- **Market Cap:** ₹86 Cr
- **Classification:** SME
- **P/E (reported):** 7.5
- **Book Value:** ₹40.28
- **Price to Book:** 1.07
- **Dividend Yield:** 1.16%
- **ROE:** 14.17%
- **ROCE:** 19%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹48.4 Cr
- **Net Income:** ₹11.4 Cr
- **EBITDA:** ₹15.9 Cr
- **52-Week High:** ₹62.99
- **52-Week Low:** ₹28.91
- **RSI (14):** 50.85

## Tapetide Score

- **Score:** 64 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Rising
- **Percentile:** 95.6 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.12 | 9% |
| growth | 60.27 | 9% |
| momentum | 78.29 | 12% |
| ownership | 34.94 | 24% |
| quality | 74.45 | 22% |
| valuation | 69.99 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 1.07 times its book value
- Company has delivered good profit growth of 68.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.9%

### Weaknesses

- Company has high debtors of 177 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 43.88% | 361.44% | 164.9% |
| ebitda margin growth | -23.08% | 9.82% | -14.38% | 147.89% |
| net income growth | 50% | 6.54% | 54% | 68% |
| revenue growth | 49.09% | 17.19% | 15% | 20% |
| roce | — | 10.92% | -80.23% | 84.43% |
| roe | — | -8.58% | 34.17% | -91.81% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 23 | 17 | 21 | 24 |
| Expenses | 14 | 15 | 17 | 15 |
| Operating Profit | 9 | 3 | 4 | 9 |
| OPM % | 38 | 16 | 19 | 37 |
| Other Income | 0 | 1 | 1 | 2 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 9 | 3 | 5 | 10 |
| Tax % | 26 | -34 | 26 | 25 |
| Net Profit | 7 | 4 | 4 | 8 |
| EPS in Rs | 4.18 | 2.1 | 1.93 | 3.77 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 17 | 26 | 28 | 42 | 37 | 43 |
| Expenses | 18 | 22 | 24 | 25 | 26 | 30 |
| Operating Profit | -1 | 4 | 4 | 17 | 12 | 13 |
| OPM % | -6 | 14 | 15 | 40 | 31 | 30 |
| Other Income | 0 | 0 | 0 | 0 | 1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | -1 | 3 | 4 | 17 | 12 | 15 |
| Tax % | -3 | 23 | 25 | 25 | 10 | 26 |
| Net Profit | -1 | 3 | 3 | 12 | 11 | 11 |
| EPS in Rs | -333.33 | 856.67 | 1036.67 | 2500 | 5.36 | 5.71 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 9 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.03 | 0.03 | 0.03 | 0.05 | 20 | 20 |
| Reserves | -1 | 1 | 5 | 17 | 49 | 61 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 9 | 5 | 8 | 2 | 2 | 6 |
| Total Liabilities | 8 | 7 | 12 | 19 | 71 | 87 |
| Fixed Assets | 1 | 0 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Assets | 7 | 6 | 12 | 18 | 70 | 83 |
| Total Assets | 8 | 7 | 12 | 19 | 71 | 87 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 3 | 5 | -3 | 6 | 8 |
| Cash from Investing Activity | -1 | 0 | -1 | -1 | -46 | 6 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 41 | 0 |
| Net Cash Flow | -1 | 3 | 3 | -4 | 1 | 14 |
| Free Cash Flow | -1 | 3 | 4 | -4 | 5 | 7 |
| CFO/OP | -26 | 108 | 135 | 6 | 62 | 88 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 93 | 12 | 16 | 114 | 163 | 177 |
| Inventory Days | — | — | — | 66 | — | — |
| Days Payable | — | — | — | 39 | — | — |
| Cash Conversion Cycle | 93 | 12 | 16 | 141 | 163 | 177 |
| Working Capital Days | -45 | -25 | -38 | 111 | 166 | 158 |
| ROCE % | — | 1069 | 133 | 153 | 28 | 21 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Promoters | 70.65% | 70.65% | 70.65% |
| FIIs | 1.16% | 1.16% | 0% |
| DIIs | 0% | 0% | 0% |
| Government | 0% | 0% | 0% |
| Public | 21.14% | 24.85% | 26.37% |
| Others | 7.05% | 3.34% | 2.98% |
| No. of Shareholders | 1374 | 1606 | 1483 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 7 / 7

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 43.23 | Sell |
| EMA (10) | 43.12 | Sell |
| SMA (20) | 43.12 | Sell |
| EMA (20) | 43.02 | Sell |
| SMA (50) | 42.65 | Buy |
| EMA (50) | 42.17 | Buy |
| SMA (100) | 39.47 | Buy |
| EMA (100) | 41.28 | Buy |
| SMA (200) | 40.14 | Buy |
| EMA (200) | 44.88 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.85 | Neutral |
| MACD (12,26,9) | 0.22 | Sell |
| Stochastic (14,3,3) | 44.8 | Neutral |
| ADX (14) | 11.5 | Neutral |
| Williams %R (14) | -57.14 | Neutral |
| ATR (14) | 1.39 | High Volatility |
| ROC (12) | -1.15 | Sell |
| Stoch RSI (14) | 25.83 | Neutral |
| UO (7,14,28) | 47.25 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f1161e0-f129-4b4e-b052-4f7b78c6298f.pdf) |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eeff3132-d378-4538-b8a6-bf7d1c067b23.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1020ec8c-ee75-483f-9435-594e72d8847a.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=888f9345-34d1-471b-9bc6-8659cd70ea96.pdf) |
| 2026-08-08 | [Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb483562-c619-4c79-8e26-9382b2e1626b.pdf) |
| 2026-07-23 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8d3d959-55fd-4700-8abd-f42d3c988830.pdf) |
| 2026-07-23 | [Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8984a962-3296-4eea-b36d-2b8af1a9a3cb.pdf) |
| 2026-07-22 | [Notice Of The Ninth Annual General Meeting For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76354384-2306-4ca9-94bf-cde63d21d67e.pdf) |
| 2026-07-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e447c2f-51ae-46cd-985d-f0a3703a904d.pdf) |
| 2026-07-17 | [Board Meeting Outcome for Outcome Of The Board Meeting Of Board Of Directors Of Amwill Health Care Limited Held On July 172026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ffe64be-0bba-4b7f-abba-fc8d1e07eacb.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-30 | [Approval Of Audited Financial Results For Half Year & FY 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99bdfd49-fa7a-4cce-ae98-14c9cd695639.pdf) |
| 2025-11-04 | [Unaudited Financial Results For The Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee27417d-5900-4c9b-a4ad-326e9ec06a42.pdf) |
| 2025-05-29 | [Audited Financial Results For The Half Year And Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1184e46-d1ab-4dd4-95d9-8552e060bf39.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Board reappointed SPR & Co. as Internal Auditor for FY2025-26 on February 09, 2026. | [Announcement Under Regulation 30(LODR)_( Reappointment Of Internal Auditor FY 2025-26) 9 Feb - Board reappointed SPR & Co. as Internal Auditor for FY2025-26 on February 09, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9dbc1646-31f0-40a4-bf8d-00b5c217438b.pdf) |
| 9 Apr - Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for 4th Quarter ended March 31, 2026 of FY 2025-26. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for 4th Quarter ended March 31, 2026 of FY 2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/deb924b8-3489-4599-8b26-f3b8742eb5ae.pdf) |
| 7 Apr - Cybersecurity incident from Feb. 18, 2026 led to SDD data loss; entries restored and certified. | [Update On Prior Intimation Regarding Cyber Security Incident. 7 Apr - Cybersecurity incident from Feb. 18, 2026 led to SDD data loss; entries restored and certified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08e8b90b-83ed-4ad2-a519-19e5f423e33e.pdf) |
| 5 Feb - Early redemption of 45,000 11% NCDs (face ₹94,000) totaling ₹423 crore; payment 9-Mar-2026; record 22-Feb-2026. | [Notice Of Early Redemption Of Non-Convertible Debentures 5 Feb - Early redemption of 45,000 11% NCDs (face ₹94,000) totaling ₹423 crore; payment 9-Mar-2026; record 22-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b8db4c8-c471-48eb-b970-e5b366e35607.pdf) |
| 4 Nov 2025 - No deviation in IPO fund utilisation for H1 FY2025-26; IPO raised Rs 4,888 lakh; unutilised Rs 1,546.61 lakh. | [SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (''''IPO") 4 Nov 2025 - No deviation in IPO fund utilisation for H1 FY2025-26; IPO raised Rs 4,888 lakh; unutilised Rs 1,546.61 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c5dbdd51-6fb1-4432-b0c1-3583bf8e24ac.pdf) |
| 4 Feb - Investor Presentation for the quarter and nine months ended 31 December 2025 | [Announcement under Regulation 30 (LODR)-Investor Presentation 4 Feb - Investor Presentation for the quarter and nine months ended 31 December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5fd10b59-2da6-49eb-9a23-9df1c4cf6b96.pdf) |
| 4 Feb - Board approved early redemption of ₹423 crore 11% NCDs (45,000) ISIN INE149K07013; original maturity 30 Sep 2031. | [Early Redemption Of Non-Convertible Debentures 4 Feb - Board approved early redemption of ₹423 crore 11% NCDs (45,000) ISIN INE149K07013; original maturity 30 Sep 2031.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a88e2f4c-eea1-49f8-91c4-abbcf35b5dbf.pdf) |
| 4 Feb - Board acknowledged ₹11,800 fine for one-day delay in prior intimation of 7 Nov 2025 meeting. | [Board Comments On Fine Levied By Stock Exchange 4 Feb - Board acknowledged ₹11,800 fine for one-day delay in prior intimation of 7 Nov 2025 meeting.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9c03cf57-76bb-46d8-a583-b7eb547e48f5.pdf) |
| 18h - Redeemed 45,000 11% secured NCDs (ISIN INE149K07013) totaling ₹423 crore on 9 Mar 2026. | [Completion Of Early Redemption Of Non-Convertible Debentures 18h - Redeemed 45,000 11% secured NCDs (ISIN INE149K07013) totaling ₹423 crore on 9 Mar 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/206a4cbe-b8bd-44ad-9bbe-81b1d20d8cf8.pdf) |
| 18 Feb - Newspaper Publication regarding notice of special window for transfer and dematerialization of physical securities | [Announcement under Regulation 30 (LODR)-Newspaper Publication 18 Feb - Newspaper Publication regarding notice of special window for transfer and dematerialization of physical securities](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86f2a1e8-7363-42b0-8194-74dc7bc60442.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from web | [Annual Report 2025 from web](https://www.bseindia.com/xml-data/corpfiling/AttachLive/60dc4618-c39c-4f55-b648-038bb5f2fd20.pdf) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9922e9b-cdc2-4549-b65f-635ca4c22299.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/60dc4618-c39c-4f55-b648-038bb5f2fd20.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d4bdd12-001e-4341-a901-1f0be9a7f884.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0d45a25-46a8-42f7-8d08-8bf713544c7a.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5abbee79-6b72-4a05-8830-17efb47c4b83.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/504918/76574504918.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/504918/70201504918.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/504918/65453504918.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/504918/5049180319.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a4be651f-e6b0-4371-849a-b6d6353fb335.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d0848d7-ec56-4a05-af03-d2faba37ecf7.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac2aea18-7348-4d34-960e-67d2b1d2a308.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aaf3b79c-db62-4377-a0d1-88f1b998fe20.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d653a908-b879-4425-9144-c8e2150dfd39.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/046069d8-1da3-4f33-85f8-f92f61a2b143.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3b77788-2ba3-44bb-8eef-524ec2d0d18e.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3687f15-eae4-48b3-a0e8-82907432745a.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/87d86105-8460-43f0-9aee-2cd0926dc4aa.pdf) |
| Jun 2021 | [Concall - Jun 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d0918a7-e600-46d7-b3d6-fcb8f3ec15d5.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:06.726Z.